430 related articles for article (PubMed ID: 24001601)
1. Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.
Murray LS; Lu Y; Taggart A; Van Regemorter N; Vilain C; Abramowicz M; Kadler KE; Van Agtmael T
Hum Mol Genet; 2014 Jan; 23(2):283-92. PubMed ID: 24001601
[TBL] [Abstract][Full Text] [Related]
2. COL4A2 mutation associated with familial porencephaly and small-vessel disease.
Verbeek E; Meuwissen ME; Verheijen FW; Govaert PP; Licht DJ; Kuo DS; Poulton CJ; Schot R; Lequin MH; Dudink J; Halley DJ; de Coo RI; den Hollander JC; Oegema R; Gould DB; Mancini GM
Eur J Hum Genet; 2012 Aug; 20(8):844-51. PubMed ID: 22333902
[TBL] [Abstract][Full Text] [Related]
3. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke.
Jeanne M; Labelle-Dumais C; Jorgensen J; Kauffman WB; Mancini GM; Favor J; Valant V; Greenberg SM; Rosand J; Gould DB
Am J Hum Genet; 2012 Jan; 90(1):91-101. PubMed ID: 22209247
[TBL] [Abstract][Full Text] [Related]
4. 4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease.
Jones FE; Murray LS; McNeilly S; Dean A; Aman A; Lu Y; Nikolova N; Malomgré R; Horsburgh K; Holmes WM; Kadler KE; Van Agtmael T
Hum Mol Genet; 2019 Feb; 28(4):628-638. PubMed ID: 30351356
[TBL] [Abstract][Full Text] [Related]
5. Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations.
Kuo DS; Labelle-Dumais C; Mao M; Jeanne M; Kauffman WB; Allen J; Favor J; Gould DB
Hum Mol Genet; 2014 Apr; 23(7):1709-22. PubMed ID: 24203695
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention.
Jeanne M; Jorgensen J; Gould DB
Circulation; 2015 May; 131(18):1555-65. PubMed ID: 25753534
[TBL] [Abstract][Full Text] [Related]
7. De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly.
Yoneda Y; Haginoya K; Arai H; Yamaoka S; Tsurusaki Y; Doi H; Miyake N; Yokochi K; Osaka H; Kato M; Matsumoto N; Saitsu H
Am J Hum Genet; 2012 Jan; 90(1):86-90. PubMed ID: 22209246
[TBL] [Abstract][Full Text] [Related]
8. Material-driven fibronectin assembly rescues matrix defects due to mutations in collagen IV in fibroblasts.
Ngandu Mpoyi E; Cantini M; Sin YY; Fleming L; Zhou DW; Costell M; Lu Y; Kadler K; García AJ; Van Agtmael T; Salmeron-Sanchez M
Biomaterials; 2020 Sep; 252():120090. PubMed ID: 32413593
[TBL] [Abstract][Full Text] [Related]
9. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.
Meuwissen ME; Halley DJ; Smit LS; Lequin MH; Cobben JM; de Coo R; van Harssel J; Sallevelt S; Woldringh G; van der Knaap MS; de Vries LS; Mancini GM
Genet Med; 2015 Nov; 17(11):843-53. PubMed ID: 25719457
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly.
Yoneda Y; Haginoya K; Kato M; Osaka H; Yokochi K; Arai H; Kakita A; Yamamoto T; Otsuki Y; Shimizu S; Wada T; Koyama N; Mino Y; Kondo N; Takahashi S; Hirabayashi S; Takanashi J; Okumura A; Kumagai T; Hirai S; Nabetani M; Saitoh S; Hattori A; Yamasaki M; Kumakura A; Sugo Y; Nishiyama K; Miyatake S; Tsurusaki Y; Doi H; Miyake N; Matsumoto N; Saitsu H
Ann Neurol; 2013 Jan; 73(1):48-57. PubMed ID: 23225343
[TBL] [Abstract][Full Text] [Related]
11. A mutation in COL4A2 causes autosomal dominant porencephaly with cataracts.
Ha TT; Sadleir LG; Mandelstam SA; Paterson SJ; Scheffer IE; Gecz J; Corbett MA
Am J Med Genet A; 2016 Apr; 170A(4):1059-63. PubMed ID: 26708157
[TBL] [Abstract][Full Text] [Related]
12. Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome.
Volonghi I; Pezzini A; Del Zotto E; Giossi A; Costa P; Ferrari D; Padovani A
Curr Med Chem; 2010; 17(13):1317-24. PubMed ID: 20166936
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of COL4A1 and COL4A2 mutations in severe fetal multifocal hemorrhagic and/or ischemic cerebral lesions.
Maurice P; Guilbaud L; Garel J; Mine M; Dugas A; Friszer S; Maisonneuve E; Moutard ML; Coste T; Héron D; Tournier-Lasserve E; Garel C; Jouannic JM
Ultrasound Obstet Gynecol; 2021 May; 57(5):783-789. PubMed ID: 32515830
[TBL] [Abstract][Full Text] [Related]
14. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.
Kuo DS; Labelle-Dumais C; Gould DB
Hum Mol Genet; 2012 Oct; 21(R1):R97-110. PubMed ID: 22914737
[TBL] [Abstract][Full Text] [Related]
15. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.
Gould DB; Phalan FC; Breedveld GJ; van Mil SE; Smith RS; Schimenti JC; Aguglia U; van der Knaap MS; Heutink P; John SW
Science; 2005 May; 308(5725):1167-71. PubMed ID: 15905400
[TBL] [Abstract][Full Text] [Related]
16. COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity.
Labelle-Dumais C; Schuitema V; Hayashi G; Hoff K; Gong W; Dao DQ; Ullian EM; Oishi P; Margeta M; Gould DB
Am J Hum Genet; 2019 May; 104(5):847-860. PubMed ID: 31051113
[TBL] [Abstract][Full Text] [Related]
17. Childhood presentation of COL4A1 mutations.
Shah S; Ellard S; Kneen R; Lim M; Osborne N; Rankin J; Stoodley N; van der Knaap M; Whitney A; Jardine P
Dev Med Child Neurol; 2012 Jun; 54(6):569-74. PubMed ID: 22574627
[TBL] [Abstract][Full Text] [Related]
18. Infantile hemiparesis and porencephaly due to a COL4A1 mutation: Gould syndrome.
Burns A; Hug J
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38355202
[TBL] [Abstract][Full Text] [Related]
19. A Novel COL4A2 Mutation Associated with Recurrent Strokes.
McHugh DC; Esenwa C
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105156. PubMed ID: 32912510
[TBL] [Abstract][Full Text] [Related]
20. Drosophila basement membrane collagen col4a1 mutations cause severe myopathy.
Kelemen-Valkony I; Kiss M; Csiha J; Kiss A; Bircher U; Szidonya J; Maróy P; Juhász G; Komonyi O; Csiszár K; Mink M
Matrix Biol; 2012 Jan; 31(1):29-37. PubMed ID: 22037604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
